ProfileGDS4718 / 207259_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 96% 62% 95% 96% 87% 78% 95% 95% 95% 92% 95% 84% 82% 85% 85% 94% 78% 84% 80% 95% 92% 95% 94% 90% 82% 92% 90% 94% 84% 82% 38% 95% 96% 77% 89% 90% 92% 94% 14% 96% 88% 73% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.297995
GSM549102patient 115, normal, homogenized [OPG study]10.662696
GSM549104patient 119, normal, homogenized [OPG study]6.288562
GSM549108patient 138, normal, homogenized [OPG study]10.313695
GSM549119patient 077, normal, homogenized [OPG study]10.82196
GSM549133patient 032, cancer, homogenized [OPG study]8.8166687
GSM549139patient 042, cancer, homogenized [OPG study]7.6814378
GSM549099patient 107, normal, homogenized [OPG study]10.249595
GSM549109patient 139, normal, homogenized [OPG study]10.21195
GSM549110patient 046, normal, homogenized [OPG study]10.42595
GSM549114patient 063, normal, homogenized [OPG study]9.7312992
GSM549122patient 082, normal, homogenized [OPG study]10.341695
GSM549134patient 033, cancer, homogenized [OPG study]8.3685684
GSM549136patient 036, cancer, homogenized [OPG study]8.1963482
GSM549140patient 044, cancer, homogenized [OPG study]8.5526185
GSM549111patient 047, normal, homogenized [OPG study]8.5382985
GSM549113patient 057, normal, homogenized [OPG study]10.240794
GSM549132patient 031, cancer, homogenized [OPG study]7.6817278
GSM549137patient 038, cancer, homogenized [OPG study]8.2955184
GSM549142patient 047, cancer, homogenized [OPG study]7.5904680
GSM549100patient 110, normal, homogenized [OPG study]10.220895
GSM549107patient 135, normal, homogenized [OPG study]9.6435192
GSM549115patient 068, normal, homogenized [OPG study]10.457695
GSM549116patient 072, normal, homogenized [OPG study]10.156994
GSM549120patient 078, normal, homogenized [OPG study]9.2792290
GSM549131patient 030, cancer, homogenized [OPG study]8.1896982
GSM549118patient 074, normal, homogenized [OPG study]9.7125392
GSM549129patient 027, cancer, homogenized [OPG study]9.1347890
GSM549123patient 088, normal, homogenized [OPG study]10.143694
GSM549124patient 006, cancer, homogenized [OPG study]8.2327884
GSM549126patient 015, cancer, homogenized [OPG study]8.1341882
GSM549128patient 025, cancer, homogenized [OPG study]4.8593738
GSM549103patient 117, normal, homogenized [OPG study]10.302795
GSM549117patient 073, normal, homogenized [OPG study]10.63896
GSM549138patient 041, cancer, homogenized [OPG study]7.5483577
GSM549141patient 045, cancer, homogenized [OPG study]9.1810289
GSM549130patient 028, cancer, homogenized [OPG study]9.0809990
GSM549101patient 111, normal, homogenized [OPG study]9.4513492
GSM549105patient 128, normal, homogenized [OPG study]9.9250994
GSM549106patient 134, normal, homogenized [OPG study]3.8691714
GSM549112patient 048, normal, homogenized [OPG study]10.526396
GSM549125patient 011, cancer, homogenized [OPG study]8.7614788
GSM549127patient 024, cancer, homogenized [OPG study]7.2385673
GSM549135patient 035, cancer, homogenized [OPG study]8.4340484